CDE issues Guiding Principles: organoids may serve as efficacy and safety evaluation models for non-clinical research of human-derived stem cell products
In recent years, with the development of stem cell technology, deepened understanding, and accumulated experience, stem cell therapy has gradually become……
Major News! Organoids Listed for the First Time in CDE Guidelines for Gene Therapy and Cell Therapy
Recently, the Center for Drug Evaluation (CDE) of the National Medical Products Administration consecutively issued three guidelines related to gene……
Shenzhen Issues "1+3" Documents on Cluster Development of the Biopharmaceutical Industry; Up to RMB 300 Million Funding for Key Cell-Drug Technology!
Recently, in order to implement the policy spirit of the "Opinions of the CPC Central Committee and the State Council on Supporting Shenzhen in Building a……
Latest news! The first stem cell clinical research project in China's plastic surgery specialty has been filed with the National Health Commission!
Stem cell research in China is accelerating, with another stem cell clinical research project filed with the National Health Commission.…
Good news! Another stem cell clinical research project has been approved by the National Health Commission
'Regenerative medicine technology', represented by stem cell technology, is the 'third medical revolution' following pharmaceutical and surgical treatment.…
Policy issued! Tianjin Free Trade Zone's pilot for clinical translational application of gene and cell therapy approved!
To pilot national systems on a broader scale and with more coordinated resources, fully leverage innovation platforms, and empower industrial innovation……
Multiple stem cell research achievements honored at the 2020 National Science and Technology Awards!
On November 3, at the 2020 National Science and Technology Awards Conference held in Beijing, multiple research achievements in the cell field received……
Guangdong releases the application guidelines for the 'Precision Medicine and Stem Cells' key special program, with a dedicated direction for product development of stem cell therapies for major refractory diseases!
The Guangdong Provincial Department of Science and Technology recently officially released the 2021–2022 Application Guidelines for the 'Precision……
The Politburo of the CPC Central Committee held a group study session on strengthening China's biosecurity development
On the afternoon of September 29, the Politburo of the CPC Central Committee held its 33rd group study session on strengthening China's biosecurity……
Shenzhen legislates for the cell and gene industry: the entire cell and gene industrial chain to be brought within the scope of promotion!
Another important Shenzhen legislation in an emerging field — the Shenzhen Special Economic Zone Regulations on Promoting the Cell and Gene Industry……
Shenzhen to legislate on the management of cell and gene therapy!
An industry boost! According to Shenzhen TV's Shenzhen News: in order to implement the requirements of the Implementation Plan for the Comprehensive……
Five Guangdong departments jointly issue document: support for the development of strategic pillar industries in biopharmaceuticals and health, including cell therapy!
Recently, five departments — the Department of Science and Technology, the Development and Reform Commission, the Department of Industry and Information……